ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MUHAMMAD ATA

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,223Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 780

$1.04M Total Retail Price of All Prescriptions

Rank: 62 out of 780

775 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 775 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

37% of this provider’s 775 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 12,100 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,855 790 S3 1 1
OMEPRAZOLE 1,166 623 2 3
LISINOPRIL 824 380 3 6
SIMVASTATIN 801 428 4 2
MELOXICAM 598 257 5 16
LEVOTHYROXINE SODIUM 564 316 6 5
GABAPENTIN 516 189 7 13
FUROSEMIDE 491 263 8 7
POTASSIUM CHLORIDE 476 290 9 11
ALENDRONATE SODIUM 473 254 10 44
METOPROLOL TARTRATE 466 302 11 19
PRAVASTATIN SODIUM 456 256 12 9
METFORMIN HCL 446 242 13 8
PREDNISONE 319 188 14 40
TRIAMTERENE-HCTZ 317 140 15 37
CEPHALEXIN 315 159 16 105
METOCLOPRAMIDE HCL 292 157 17 102
DOXAZOSIN MESYLATE 253 197 18 97
AMITRIPTYLINE HCL 241 135 R 19 48
NAPROXEN 227 65 20 100
CITALOPRAM HBR 223 115 21 23
RANITIDINE HCL 219 93 22 39
AMLODIPINE BESYLATE 219 147 22 4
WARFARIN SODIUM 215 131 24 24
PANTOPRAZOLE SODIUM 212 58 25 25
DICLOFENAC SODIUM 205 79 26 137
ENALAPRIL MALEATE 198 132 27 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 194 133 28 26
NEXIUM 187 87 29 22
GLYBURIDE 183 119 R 30 101
TRAMADOL HCL 183 115 30 15
FLUTICASONE PROPIONATE 178 61 32 41
ZOLPIDEM TARTRATE 176 104 33 17
LACTULOSE 162 61 34 178
SULFAMETHOXAZOLE-TRIMETHOPRIM 159 76 35 88
PROAIR HFA 147 38 36 62
DIGOXIN 143 112 37 56
SINGULAIR 133 71 38 73
LOSARTAN POTASSIUM 131 96 39 18
OXYBUTYNIN CHLORIDE 126 58 40 148
PHENYTOIN SODIUM EXTENDED 124 26 41 128
ATENOLOL 124 37 41 21
TERAZOSIN HCL 119 66 43 160
VENTOLIN HFA 119 46 43 91
ZETIA 119 36 43 94
ETODOLAC 118 59 46 174
VERAPAMIL ER 116 54 47 78
THEOPHYLLINE ANHYDROUS 115 84 48 185
PAROXETINE HCL 113 64 49 69
CYCLOBENZAPRINE HCL 113 41 R 49 42
CARVEDILOL 110 67 51 14
TRAZODONE HCL 109 54 52 35
AZITHROMYCIN 106 55 53 38
CARBAMAZEPINE 105 0 54 257
CIPROFLOXACIN HCL 103 59 55 49
CRESTOR 97 45 56 32
FINASTERIDE 95 62 57 150
SERTRALINE HCL 95 38 57 27
DIVALPROEX SODIUM 93 12 59 119
METOPROLOL SUCCINATE 92 46 60 20
AMOXICILLIN 90 47 61 99
SPIRONOLACTONE 88 51 62 53
ALLOPURINOL 87 61 63 29
CARISOPRODOL 87 24 R 63 67
LEVOFLOXACIN 86 64 65 76
LOSARTAN-HYDROCHLOROTHIAZIDE 85 75 66 33
FLUOXETINE HCL 84 35 67 65
INSULIN SYRINGE 82 38 68 80
LOVASTATIN 81 61 69 47
ATORVASTATIN CALCIUM 81 47 69 12
LEVETIRACETAM 80 0 71 130
BUSPIRONE HCL 80 47 71 125
TAMSULOSIN HCL 79 50 73 36
CLOTRIMAZOLE-BETAMETHASONE 79 35 73 166
MECLIZINE HCL 78 51 75 83
NOVOLIN 70-30 76 30 76 164
CLOPIDOGREL 75 55 77 34
SPIRIVA 75 61 77 72
LYRICA 75 26 77 52
HYDROCHLOROTHIAZIDE 75 38 77 10
TOPIRAMATE 75 0 77 145
DIVALPROEX SODIUM ER 72 0 82 216
ZOSTAVAX 72 48 82 225
GLIPIZIDE 69 40 84 74
ISOSORBIDE MONONITRATE ER 69 49 84 60
GEMFIBROZIL 67 16 86 104
GLYBURIDE MICRONIZED 67 36 R 86 325
LOVAZA 67 37 86 183
LAMOTRIGINE 67 0 86 205
RISPERIDONE 67 41 86 98
HUMULIN 70-30 66 31 91 106
DILTIAZEM 24HR CD 65 36 92 138
MIRTAZAPINE 65 14 92 58
ENDOCET 63 0 S2 94 129
TRICOR 60 12 95 152
ENALAPRIL-HYDROCHLOROTHIAZIDE 60 32 95 239
MONTELUKAST SODIUM 59 25 97 120
IBUPROFEN 57 22 98 93
FEXOFENADINE HCL 55 30 99 275
NEOMYCIN-POLYMYXIN-DEXAMETH 55 31 99 430
ESTRADIOL 54 21 R 101 122
OXCARBAZEPINE 54 0 101 276
METHOTREXATE 54 42 101 252
SYMBICORT 54 39 101 181
CEFUROXIME 53 27 105 147
DONEPEZIL HCL 53 53 105 31
CLONIDINE HCL 51 28 107 28
PREMARIN 51 0 R 107 110
HYDROXYZINE HCL 51 23 R 107 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.